[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

December 2019 | 439 pages | ID: C3146CB7808EN
GlobalData

US$ 3,000.00 US$ 4,000.00 -25 %
Offer valid until October 17, 2020!

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019' provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Colorectal Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Colorectal Cancer Diagnostic Tests Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory
3.3 Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
3.5 Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials

4 COLORECTAL CANCER DIAGNOSTIC TESTS - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Colorectal Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
4.2 Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development

5 COLORECTAL CANCER DIAGNOSTIC TESTS COMPANIES AND PRODUCT OVERVIEW

6 COLORECTAL CANCER DIAGNOSTIC TESTS - RECENT DEVELOPMENTS

7 APPENDIX

LIST OF TABLES

Table 1: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials
Table 6: Colorectal Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
Table 7: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 8: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Status
Table 10: Diagnostic Assay - Colorectal Cancer Diagnostic Tests - Product Description
Table 11: Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 12: DNA Damage Response Deficiency Assay - Colorectal Cancer Diagnostic Tests - Product Status
Table 13: DNA Damage Response Deficiency Assay - Colorectal Cancer Diagnostic Tests - Product Description
Table 14: Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Veracode - Colorectal Cancer Diagnostic Tests - Product Status
Table 16: Veracode - Colorectal Cancer Diagnostic Tests - Product Description
Table 17: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Parsortix-Based Test - Colorectal Cancer Diagnostic Tests - Product Status
Table 19: Parsortix-Based Test - Colorectal Cancer Diagnostic Tests - Product Description
Table 20: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Cchek - Colon Cancer Confirmatory Test - Product Status
Table 22: Cchek - Colon Cancer Confirmatory Test - Product Description
Table 23: Cchek - Colon Cancer Recurrence Test - Product Status
Table 24: Cchek - Colon Cancer Recurrence Test - Product Description
Table 25: Cchek - Colon Cancer Screening Test - Product Status
Table 26: Cchek - Colon Cancer Screening Test - Product Description
Table 27: Cchek - Colon Cancer Treatment Monitoring Test - Product Status
Table 28: Cchek - Colon Cancer Treatment Monitoring Test - Product Description
Table 29: Anixa Diagnostics Corporation - Ongoing Clinical Trials Overview
Table 30: Cchek - Colon Cancer Screening Test - Cchek Cancer Patient Efficacy Study
Table 31: Cchek - Colon Cancer Screening Test - The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors
Table 32: Applied Proteomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: SimpliPro Colon-A - Product Status
Table 34: SimpliPro Colon-A - Product Description
Table 35: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Status
Table 37: Biomarker Test - Colorectal Cancer Diagnostic Tests - Product Description
Table 38: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Finger Stick Test - Colon Cancer - Product Status
Table 40: Finger Stick Test - Colon Cancer - Product Description
Table 41: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview
Table 42: ArtemixRx Prognostic Test - Colon Cancer - Product Status
Table 43: ArtemixRx Prognostic Test - Colon Cancer - Product Description
Table 44: Avant Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: TheraLink Assay - Colorectal Cancer Diagnostic Tests - Product Status
Table 46: TheraLink Assay - Colorectal Cancer Diagnostic Tests - Product Description
Table 47: Bio Mark Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Diagnostic Test - Colorectal Adenoma - Product Status
Table 49: Diagnostic Test - Colorectal Adenoma - Product Description
Table 50: Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Idylla MSI CDx - Product Status
Table 52: Idylla MSI CDx - Product Description
Table 53: Idylla MSI Test - Product Status
Table 54: Idylla MSI Test - Product Description
Table 55: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: VeriStrat - Colorectal Cancer Diagnostic Tests - Product Status

LIST OF FIGURES

Figure 1: Colorectal Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Colorectal Cancer Diagnostic Tests - Pipeline Products by Territory
Figure 3: Colorectal Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Colorectal Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Figure 5: Colorectal Cancer Diagnostic Tests - Ongoing Clinical Trials

COMPANIES MENTIONED

Abcodia Ltd
Almac Diagnostic Services Ltd
Ambergen Inc
ANGLE plc
Anixa Diagnostics Corporation
Applied Proteomics Inc
Arizona State University
Arrayit Corporation
ArtemixRx
Avant Diagnostics Inc
Bio Mark Ltd
Biocartis Group NV
Biodesix Inc
BioMarCare Technologies Ltd
BioMark Diagnostics Inc
BioMarker Strategies LLC
Biomoda Inc
Bioprognos SL
BioSystems International
Biotron Ltd
Calviri Inc
Castle Biosciences Inc
Catholic University of Leuven
Celcuity Inc
CellMax Life Inc
Cellmid Ltd
Ceres Nanosciences Inc
Cernostics Inc
ChemImage Corp
China Sky One Medical Inc
Columbia University
CS-Keys, Inc. (Inactive)
Di.V.A.L Toscana srl
DiagnoCure Inc. (Inactive)
Diazyme Laboratories Inc
DNAlytics SA
Duke University
EDP Biotech Corporation
EntreChem SL
Epigenomics AG
Eurobio Scientific SA
Eventus Diagnostics Inc (Inactive)
Exact Sciences Corp
Exiqon AS
Exosomics Siena SpA
Fina Biotech SL
Fox Chase Cancer Center
GenExosome Technologies Inc
GenomicTree Inc
German Cancer Research Center
Ghent University
GlycoZym
GoodGut SL
Health Discovery Corp
Hitachi Chemical Diagnostics Inc
Human Metabolome Technologies Inc
Ikonisys Inc
Institute of Molecular and Translational Medicine
InterGenetics Inc
IV Diagnostics Inc
Johns Hopkins University
King Abdullah University of Science and Technology
Kyo Diagnostics KK
Lab21 Ltd
Laboratorios Alpha San Ignacio Pharma S.L.
Leitat Technological Center
Lightsphere Diagnostics
Lineage Cell Therapeutics Inc
MabCure Inc
Master Diagnostica Sociedad Limitada
Matrix-Bio Inc
Max Delbruck Center for Molecular Medicine
Mayo Clinic
MDNA Life Sciences Inc
MDxHealth SA
Merrimack Pharmaceuticals Inc
Metabolon Inc
MetaStat Inc
Milagen Inc
Myriad Genetics Inc
Nanocytomics LLC
Norda ASA
Novel Bio-spectrum Technologies Inc (Inactive)
Nuclea Biotechnologies Inc. (Inactive)
Oncimmune (USA) LLC
Onconome, Inc. (Inactive)
OncoStem Diagnostics Pvt. Ltd
On-Q-ity, Inc. (Inactive)
Origin Sciences Ltd
Orion Genomics LLC
OTraces Inc.
Oxford Cancer Biomarkers Ltd
Oxford Gene Technology Ltd
PleX Diagnostics Inc (Inactive)
Precision Biologics Inc
Prediction Sciences LLC (Inactive)
PreMD Inc (Inactive)
Prescient Medicine LLC
Protagen AG
Protein Alternatives SL
Qiagen NV
Quest Diagnostics Inc
Rabin Medical Center
Rhythm Biosciences Ltd
RISE Life Science Corp
Rosetta Genomics Ltd
Scienion AG
Seegene Inc
Shuwen Biotech Co Ltd
Sysmex Corp
Tel Aviv University
The Chinese University of Hong Kong
The Walter and Eliza Hall Institute of Medical Research
TheraDiag SA
Treos Bio Inc
Trinity College Dublin
Universal Diagnostics SL
University of Illinois at Chicago
University of Lyon
University of Michigan
University of Notre Dame
University of Pittsburgh
University of Texas MD Anderson Cancer Center
University of Turku
University of Washington
University of Wisconsin Madison
University of Zurich
US Biomarkers Inc
vall d hebron institut de Recerca
Vanderbilt University
Vastcon Inc
Viomics Inc.
VolitionRX Ltd
XEPTAGEN SpA


More Publications